secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001411690-26-000006
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Q4 2025 revenue $8.0M (-3% YoY); FY revenue $28.5M (-7%)
----------------------------------------------------------------

- Q4 2025 revenue $8.0M vs $8.2M Q4 2024; consumables/software revenue down 1%.
- Full-year 2025 revenue $28.5M vs $30.8M FY2024; consumables/software up 7%.
- Q4 gross margin 43% (42% prior); non-GAAP gross margin also 43%.
- Operating expenses reduced 22% to $11.9M in Q4; installed base 387 systems (+4%).
- Company provided 2026 revenue outlook (specific figures not available in excerpt).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000006/0001411690-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000006/bngo-20260323.htm
  HTML page:      https://secwatch.observer/filing/0001411690-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer